Answers are grounded in this paper and cite their sources.
Candida albicans is a leading cause of mycotic death in immunocompromised populations. Antifungal therapies against invasive fungal diseases are limited to three drug classes, and the efficacy of these agents is compromised by resistance development. Here, we leveraged a pooled functional genomic screening strategy to identify C. albicans genes that modulate susceptibility to the conventional antifungals caspofungin and fluconazole, as well as emerging antifungals nikkomycin Z and manogepix. Transcriptional repression of SNF6 and PAT1 conferred hypersensitivity to manogepix, implicating the SWI/SNF complex as a general regulator of stress and Pat1 as a regulator of manogepix-induced stress through its role in governing P-body formation. Furthermore, transcriptional repression of spliceosome components impaired mRNA splicing of the septin CDC3 , resulting in septin mislocalization and altered cell wall homeostasis, thereby increasing sensitivity to nikkomycin Z. Overall, understanding the genes influencing antifungal susceptibility is crucial for developing effective treatments and for understanding mechanisms of resistance.
No takes yet. Share an insight, caveat, or question.
Pavlova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: